Education
About Us
Working with TipRanks
Follow Us
BioHarvest Sciences (BHST)
NASDAQ:BHST
Total Valuation
BioHarvest Sciences has a market cap or net worth of $152.71M. The enterprise value is $135.54M.
Market Cap$152.71M
Enterprise Value$135.54M
Share Statistics
BioHarvest Sciences has 17,333,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,333,430
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioHarvest Sciences’s return on equity (ROE) is -9.71 and return on invested capital (ROIC) is -45.35%.
Return on Equity (ROE)-9.71
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-45.35%
Return on Capital Employed (ROCE)-0.65
Revenue Per Employee289.52K
Profits Per Employee-148.43K
Employee Count87
Asset Turnover1.01
Inventory Turnover3.08
Valuation Ratios
The current PE Ratio of BioHarvest Sciences is ―. BioHarvest Sciences’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value75.25
Price to FCF―
Price to Operating Cash Flow-19.23
PEG Ratio―
Income Statement
In the last 12 months, BioHarvest Sciences had revenue of 25.19M and earned -12.91M in profits. Earnings per share was -0.80.
Revenue25.19M
Gross Profit13.94M
Operating Income-6.99M
Pretax Income-12.90M
Net Income-12.91M
EBITDA-9.72M
Earnings Per Share (EPS)-0.80
Cash Flow
In the last 12 months, operating cash flow was -7.03M and capital expenditures -2.18M, giving a free cash flow of -9.21M billion.
Operating Cash Flow-7.03M
Free Cash Flow-9.21M
Free Cash Flow per Share-0.53
Dividends & Yields
BioHarvest Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change57.91%
50-Day Moving Average7.93
200-Day Moving Average6.57
Relative Strength Index (RSI)61.86
Average Volume (3m)23.48K
Important Dates
BioHarvest Sciences upcoming earnings date is Dec 1, 2025, TBA (Not Confirmed).
Last Earnings DateAug 11, 2025
Next Earnings DateDec 1, 2025
Ex-Dividend Date―
Financial Position
BioHarvest Sciences as a current ratio of 0.55, with Debt / Equity ratio of -499.46%
Current Ratio0.55
Quick Ratio0.29
Debt to Market Cap0.04
Net Debt to EBITDA-1.18
Interest Coverage Ratio-3.62
Taxes
In the past 12 months, BioHarvest Sciences has paid 8.00K in taxes.
Income Tax8.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BioHarvest Sciences EV to EBITDA ratio is -11.47, with an EV/FCF ratio of -11.71.
EV to Sales4.43
EV to EBITDA-11.47
EV to Free Cash Flow-11.71
EV to Operating Cash Flow-16.68
Balance Sheet
BioHarvest Sciences has $3.73M in cash and marketable securities with $21.09M in debt, giving a net cash position of $17.36M billion.
Cash & Marketable Securities$3.73M
Total Debt$21.09M
Net Cash$17.36M
Net Cash Per Share$1.00
Tangible Book Value Per Share$0.08
Margins
Gross margin is 58.02%, with operating margin of -27.75%, and net profit margin of -51.27%.
Gross Margin58.02%
Operating Margin-27.75%
Pretax Margin-51.23%
Net Profit Margin-51.27%
EBITDA Margin-38.61%
EBIT Margin-43.57%
Analyst Forecast
The average price target for BioHarvest Sciences is $11.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$11.67
Price Target Upside32.46% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast57.83%
EPS Growth Forecast40.94%